Report in Medical Technology

BioVex to Report Phase I/II Clinical Trial Results for the Front Line Treatment of Head and Neck Cancer With OncoVEX GM-CSF at the 2009 American Society of Clinical Oncology Meeting

WOBURN, Mass., May 15 /PRNewswire/ -- BioVex Inc, a company developing next generation biologics for the treatment and prevention of cancer and infectious disease, announced today that the results from a Phase I/II combination study in previously untreated patients with head and neck cancer will...

BioInformatics, LLC New Report - Capitalizing on New Opportunities for Stem Cell Products, Now Available

ARLINGTON, Va., May 5 /PRNewswire/ -- BioInformatics, LLC announces the release of its newest report, Capitalizing on New Opportunities for Stem Cell Products. Despite a sluggish economy and cuts being made to laboratory budgets, the market for stem cell research products is expected to increa...

Transcept Pharmaceuticals to Report First Quarter 2009 Results

RICHMOND, Calif., May 5 /PRNewswire-FirstCall/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT ), a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience, today announced it...

New Report Shows Record Number of Medicines in Development to Treat Leading Causes of Cancer

DENVER, April 1 /PRNewswire-USNewswire/ -- Responding to President Obama's call for "a cure for cancer in our time," the Pharmaceutical Research and Manufacturers of America (PhRMA) delivered a new report today on medicines in the research pipeline for cancer. The report shows that America's pharm...

New Report by BioTrends Research Group to Highlight the Launch of ULORIC(R) (febuxostat)

EXTON, Pa., Feb. 24 /PRNewswire/ -- BioTrends is pleased to announce the fielding of a new syndicated report, LaunchTrends(TM): Uloric (R) . Takeda Pharmaceutical Company Limited announced that they received FDA approval for Uloric (R) (generic name: febuxostat) on February 13, 2009. Ul...

InterMune to Report Top-Line Results of Triple Combination Study of ITMN-191 in January 2009

BRISBANE, Calif., Dec. 10 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today said that it will report top-line results in January 2009 from its Phase 1b clinical trial of protease inhibitor ITMN-191 (R7227) in combination with standard-of-care Pegasys(R) (peginterferon alfa-2a) and ...

Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period

Results of FLEXX Trial Presented at the Osteoarthritis Research Society International's 2008 World Congress PARSIPPANY, N.J., Oct. 7 /PRNewswire/ -- Ferring Pharmaceuticals Inc. recently presented results from the FLEXX Trial of Osteoarthritis of the Knee, showing that EUFLEXXA(R) (1% sodium...

FluoroPharma, Inc. to Report Preclinical Data on Alzheimer's Disease and Prostate Cancer PET Imaging Agents

BOSTON, Sept. 8 /PRNewswire/ -- FluoroPharma, Inc. announced today that Dr. David Elmaleh, FluoroPharma's founder and Chief Scientific Advisor, will report on two preclinical studies demonstrating the potential of novel Positron Emission Tomography (PET) molecular imaging agents for detection ...

Artelis and Selexis Report Record Antibody Production Levels in CHO Cells of Over 31 Grams Per Liter

BRUSSELS, Belgium and GENEVA, Sept. 3 /PRNewswire/ -- Artelis SA and Selexis SA announced today a new milestone in CHO based monoclonal antibody production with the achievement of manufacturing yields of over 31 grams per liter. This record level was accomplished by applying two highly innovat...

Previous Claims of siRNA Therapeutic Effects Called into Question by Report in 'Human Gene Therapy'

NEW ROCHELLE, N.Y., Sept. 2 /PRNewswire/ -- The many recent reports documenting the therapeutic efficacy of short interfering RNAs (siRNAs) in animal models of human disease may actually be describing non-specific therapeutic effects related to the ability of siRNA to activate an immune respon...

New AVAC Report on Pre-Exposure Prophylaxis Calls for Immediate Planning to Anticipate Study Results of Potential New HIV Prevention Option

Now is the time to anticipate and plan for various study outcomes MEXICO CITY, Aug. 3 /PRNewswire/ -- The AIDS Vaccine Advocacy Coalition (AVAC) today released a new report, Anticipating the Results of PrEP Trials, calling for increased action from governments, global health institutions, d...

Interleukin Genetics Launches Enhanced Heart Health Genetic Test Report Format

Report Includes an Individual's Genetic Risk Based on Clinical Data, Preventive Measure Guidance and Scientific Educational Materials WALTHAM, Mass., July 22 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (Amex: ILI ), today announced the launch of an enhanced test report format an...

BioVex to Report Phase II Clinical Trial Results of OncoVEX GM-CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting

WOBURN, Mass., May 16 /PRNewswire/ -- BioVex Inc, a biotechnology company developing clinical stage products in oncology and infectious disease, announced today that the abstract describing the interim results from its Phase II clinical trial of OncoVEX GM-CSF in advanced metastatic melanoma i...

Vermillion and the Ohio State University Report That Novel Diagnostic Test May Help Predict Risk for Relapse of TTP, A Serious Blood Disorder

- Findings Published in the British Journal of Hematology - FREMONT, Calif., April 24 /PRNewswire-FirstCall/ -- Vermillion, Inc. (Nasdaq: VRML ) today reported findings from an Ohio State University (OSU) clinical study that indicated that a surface-enhanced laser desorption/ionization ...

Independent Studies Report on Possible Roles for Cylex's Immune Cell Function Assay in Monitoring of Heart and Lung Transplant Recipients

Six different studies will report on use of ImmuKnow assay in presentations at the annual meeting of the International Society for Heart and Lung Transplantation COLUMBIA, Md., April 9 /PRNewswire/ -- Since it was initially cleared as an in vitro diagnostic techniqu...

New Report Offers Hope for Closing Health Gap for African Americans, With Nearly 700 Medicines in Pipeline

JACKSON, Miss., Dec. 10 /PRNewswire-USNewswire/ -- The Pharmaceutical Research and Manufacturers of America (PhRMA) delivered a new report on medicines in the research pipeline for major diseases affecting African Americans to Mississippi Governor Haley Barbour today. The report found that Ame...

New UNAIDS Report Offers Encouraging News, But Most HIV-Positive Mothers Still Not Getting the Care & Treatment They Need

WASHINGTON, Nov. 20 /PRNewswire-USNewswire/ -- The following statement was released today by Pamela W. Barnes, President and Chief Executive Officer of the Elizabeth Glaser Pediatric AIDS Foundation: "Four years after the President's Emergency Plan for AIDS Relief (PEPFAR) began funding trea...

Grantees of the Avon Foundation Breast Cancer Prevention Research Initiative Gather in Houston to Report Interim Findings

Unique Collaborative Meeting Includes Leading Scientists Investigating Pregnancy and Breast Cancer Prevention HOUSTON, Nov. 15 /PRNewswire/ -- Eighteen scientists investigating novel means for primary prevention of breast cancer by studying the natural impact of pregnancy on b...

American Legion Anticipates Institute of Medicine Report on Gulf War Veterans

WASHINGTON, Nov. 14 /PRNewswire-USNewswire/ -- The American Legion welcomes the findings of an Institute of Medicine (IOM) report on Deployment Related Stress scheduled to be released on Nov 14. "In view of the serious and widespread impact of stress on the health of military personnel who h...

Video: Quest Diagnostics Health Trends(TM) Report Shows Significant Gap in Care for Patients With Chronic Kidney Disease

MADISON, N.J., Nov. 6 /PRNewswire-FirstCall/ -- The majority of people with diabetes and/or high blood pressure -- the two leading causes of chronic kidney disease (CKD) -- are not receiving recommended tests to identify this disease early, when medical treatment can slow or halt disease progr...

Pharmion and MethylGene Report Preliminary MGCD0103 Clinical Data at the 2007 AACR-NCI-EORTC International Conference

- Safety and response data from Phase I/II MGCD0103 combination trial with Gemzar(R) in patients with solid tumors presented - - Preliminary evidence of activity in pancreatic cancer - - Phase II portion of the clinical trial in pancreatic cancer patients has ...

Mayo Clinic Physicians Report Findings from Research on Sleep Disorders

Researchers share updates about sleep apnea and sleep behavior disorders ROCHESTER, Minn., Oct. 24 /PRNewswire-USNewswire/ -- Mayo Clinic physicians offered updates about diagnosing and treating patients with a variety of sleep disorders, including obstructive sleep apnea and sleep behavior ...

UPDATE: New Report by Pediatricians Finds Gaps in Preparing to Protect Kids From Pandemic Flu, Offers Recommendations

Email address corrected WASHINGTON, Oct. 16 /PRNewswire-USNewswire/ -- The following is being issued by Trust for America's Health: WHAT: Press briefing conference call to discuss a new report from the American Academy of Pediatrics (AAP) and Trust for America's Health (TFAH), "Pandemic In...

New Report by Pediatricians Finds Gaps in Preparing to Protect Kids From Pandemic Flu, Offers Recommendations

WASHINGTON, Oct. 15 /PRNewswire-USNewswire/ -- The following was released today by Trust for America's Health: WHAT: Press briefing conference call to discuss a new report from the American Academy of Pediatrics (AAP) and Trust for America's Health (TFAH), "Pandemic Influenza: Warning, Child...

Researchers Report First Successful Treatment of Chronic Traumatic Brain Injury

ARLINGTON, Va., Oct. 11 /PRNewswire/ -- The American Association of Health Freedom and the International Hyperbaric Medical Association announced today that physician-researchers at the Baromedical Research Institute and Louisiana State University School of Medicine, New Orleans have reported ...

Peregrine Researchers Report Data Showing Bavituximab's Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease

- Adding Bavituximab to Standard Regimen of Androgen Deprivation and Chemotherapy Reduced Size of Formerly Resistant Tumors by More than Half - - Data Further Confirm Bavituximab's Potential to Enhance Multiple Combination Regimens for Cancer Therapy - ATLANTA, and TUSTIN, C...

McCaughey Urges Use of First NYS Hospital Infection Report

NEW YORK, June 30 /PRNewswire-USNewswire/ -- Betsy McCaughey of the Committee to Reduce Infection Deaths (RID) urges families to make use of hospital infection rates made available by the NYS Department of Health today. "Now patients can learn which hospitals in their area have the lowest infecti...

Gene Found Activated in 70% of Prostate Cancer Cases, George Washington University Medical Center Scientists Report

DRS. PATRICIA BERG AND ARNOLD SCHWARTZ LED TEAM, Article in Modern Pathology set for print publication January 2009 BERG HAD ALSO DISCOVERED SAME GENE'S ACTIVATION IN MAJORITY OF BREAST CANCER CASES WASHINGTON, Oct. 24 /PRNewswire-USNewswire/ -- A gene has been found activated in 70% of pr...

'Snapshots' of Eyes Could Serve as Early Warning of Diabetes or Diabetic Eye Disease, U-M Researchers Report

FA imaging, invented at U-M, measures metabolic stress in retina ANN ARBOR, Mich., July 14 /PRNewswire-USNewswire/ -- A new vision screening device, already shown to give an early warning of eye disease, could give doctors and patients a head start on treating diabetes and its vision complic...

Landscape for Lung Cancer Therapies is Focus of New Post-ASCO MedPredict Report

SCOTTSDALE, Ariz., June 26 /PRNewswire/ -- MedPredict has published a new report in its oncology series entitled "Thought Leader Insight & Analysis: Lung Cancer," designed to provide critical strategic insight for pharma and biotech companies with a stake in the market for diagnostics and trea...

Vical Promotes Melanoma Awareness Month With Allovectin-7(R) Video Report

SAN DIEGO, April 23 /PRNewswire-FirstCall/ -- Vical Incorporated (Nasdaq: VICL ) today announced the release to television news stations nationwide of an independently produced video report featuring metastatic melanoma patients treated with the company's Allovectin-7(R) immunotherapeutic pro...

Use of PressureWire(R) Yields a More Accurate Assessment of Translesion Pressure Gradients in Peripheral Vasculature, Two New Studies Report

UPPSALA, Sweden, and WILMINGTON, Mass., March 28 /PRNewswire/ -- Use of a low profile PressureWire yields a more accurate assessment of translesion pressure gradients when compared to catheter-derived pressure gradient (CPG) measurements, according to a paper published in the Journal of Interv...

Rapid Growth of Asia-Pacific Clinical Trials Market Focus of New CenterWatch Report

BOSTON, Feb. 6 /PRNewswire/ -- CenterWatch, a publishing and information services company focused on market research about clinical trials, finds in a new report that the Asia-Pacific region is grabbing an increasing share of the global clinical trial market, and with new regulatory changes ac...

U.S. Meat Industry Will Respond to World Cancer Research Fund Report

WASHINGTON, Oct. 31 /PRNewswire-USNewswire/ -- American Meat Institute Foundation Vice President of Scientific Affairs Dr. Randy Huffman will offer a response to the World Cancer Research Fund report, slated for release October 31. Dr. Huffman will be available at the National Press Club follo...

You May Have a Thyroid Problem and Not Know It - Particularly If You're Over 60, Says a New Harvard Medical School Report

BOSTON, Aug. 9 /PRNewswire-USNewswire/ -- Doctors often mistake the symptoms of thyroid disease for another disorder such as heart failure, high cholesterol, or even dementia, says a new edition of a report from Harvard Medical School. The symptoms of thyroid diseases are so wide-ranging, part...

First-of-its-Kind National Report Reveals Estimated High Prevalence and Heavy Cost of Type 2 Diabetes Complications in America

In Response, Health Organizations Unite to Help Educate on Good Diabetes Management and How to Reduce the Risk of Other Serious Health Problems SEATTLE, April 10, 2007 /PRNewswire/ -- A first-of-its-kind report looking at the prevalence and cost of type 2 diabetes complications shows that an estim...

King Pharmaceuticals Announces Plan to Report Positive Data from Phase III Clinical Trial Evaluating the Combination of Altace with Hydrochlorothiazide

BRISTOL, Tenn.--(BUSINESS WIRE)--Apr 19, 2007 - King Pharmaceuticals, Inc. (NYSE:KG) announced today that the Company has positive top-line results from the Phase III clinical trial evaluating the efficacy and safety of the Company's ALTACE(R) (ramipril) diuretic fixed-dose combination product. The...

Cobalis Expects to Report Phase III Top-Line Results in May

IRVINE, Calif.--(BUSINESS WIRE)--Apr 30, 2007 - Cobalis Corp. (OTC BB: CLSC), a pharmaceutical development company specializing in anti-allergy medications, today announced it has been informed by its independent contract research organization that it would need more time to combine Cobalis' three ...

New Report Illuminates Ampligen's Unique Mechanism of Action

PHILADELPHIA--(BUSINESS WIRE)--Apr 30, 2007 - Hemispherx Biopharma, Inc. (AMEX: HEB) announced today the first scientific publication (Journal of Immunology, April 2007) that explains the unique therapeutic properties of its proprietary experimental therapeutic, Ampligen(R) (Poly I : Poly C(12)U), ...

Ad hoc: Interim report about clinical trial of BF-200 ALA in actinic keratosis

LEVERKUSEN, Germany, 30 April 2007 - Biofrontera AG announced that an interim report regarding the clinical study of BF-200 ALA in actinic keratosis was received today from an independent review committee. The objectives of the study are to investigate the efficacy and safety of several doses of B...